Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05476588 · ClinicalTrials.gov registry record · NA
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform
A NA study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT05476588 is a NA study that has completed, run by Baylor Research Institute. The registered enrollment target is 1,000 participants.
The verdict
NCT05476588, a NA study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.
Interventions
- OTHER Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2024-03-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05476588
The ClinicalTrials.gov registry entry for NCT05476588 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Screening is the first listed.
NCT05476588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05476588 about?
NCT05476588 is a clinical study titled "Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform". The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.
What is the current status of trial NCT05476588?
This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2022-07-15. Estimated completion is 2024-03-14.
What interventions are being tested in trial NCT05476588?
The interventions under investigation include: Screening (OTHER).
Who is sponsoring clinical trial NCT05476588?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.